Form 8-K - Current report:
SEC Accession No. 0001193125-25-247692
Filing Date
2025-10-23
Accepted
2025-10-23 07:45:25
Documents
11
Period of Report
2025-10-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sln-20251023.htm   iXBRL 8-K 58362
2 PRESS RELEASE sln-ex99_1.htm EX-99.1 27114
  Complete submission text file 0001193125-25-247692.txt   242420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20251023.xsd EX-101.SCH 54707
14 EXTRACTED XBRL INSTANCE DOCUMENT sln-20251023_htm.xml XML 6330
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 251411405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)